Glenmark gets ANDA approval for sirolimus tablets
MUMBAI, India — Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration for sirolimus tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV. According to IQVIATM sales data for the 12 month period ending